Antibe Therapeutics Inc(Pre-Merger) ATBPF

GUD is halted. Anyone know why?

[MikeStock]

Just noticed it this morning.

[MrMugsy]

There's always a chance that it really isn't halted. But ... If halted, hoping they announce a partnership in Mexico or ... better explain the redactions located in their Exelon drug agreement with Novartis.  Either would work for me !

[MikeStock]

It's now showing up in IIROC as halted. Wasn't earlier when I first posted. Hopefully something good.

[MrMugsy]

Thanks Mike ... yes I see that now. Hope it's good news !

[Layth1990]

Is this related to ATE ? 

[123ABC]

Typical pumpers

[MrMugsy]

I don't think anyone knows if it's connected Lath. GUD is a big part of ATE future sales (all drugs) in Canada, Russia, Israel, South Africa. Some also believe GUD might make a run for rights in LATAM. There are many here who follow both (assuming). That's why Mike brought it up.  That's all.

[Layth1990]

I didn't know that ! Thanks 

[Pandora]

Not anymore.   Knight Therapeutics to resume at 7 a.m. PT   2021-05-13 09:29 ET - Resume Trading   Knight Therapeutics Inc. will resume at 7 a.m. PT on Thursday, May 13, 2021. © 2021 Canjex Publishing Ltd. All rights reserved.

[Forestview]

Looks like it was halted for a change in leadership announcement. https://financialpost.com/globe-newswire/knight-therapeutics-announces-leadership-change#:~:text=(TSX%3A%20GUD)%20(%E2%80%9C,%2C%20effective%20September%201%2C%202021.&text=Also%20effective%20September%201%2C%202021,the%20role%20of%20lead%20director.

[Pandora]

  Knight president Sakhia to become CEO Sept. 1   2021-05-13 13:23 ET - News Release   Ms. Samira Sakhia reports KNIGHT THERAPEUTICS ANNOUNCES LEADERSHIP CHANGE Samira Sakhia will assume the role of president and chief executive officer, Knight Therapeutics Inc., effective Sept. 1, 2021. Ms. Sakhia currently serves as Knight's President and Chief Operating Officer.